The FDA has accepted for review the New Drug Application for a 25mg oral formulation of semaglutide for chronic weight management.

Wegovy and Ozempic are both semaglutide weight loss medications, but they’re prescribed differently based on who qualifies. Compare side effects here.

Interest in weight-loss products continues to surge as calls come for a faster rollout of treatments on the NHS. Research by ...

Weight loss of 5% or greater was achieved by 79.2% of patients on semaglutide 25mg vs 31.1% of those on placebo (P <.0001). Semaglutide-treated patients also saw significant improvements in ...

Semaglutide — known by brand names Ozempic and Wegovy — works in the brain to impact satiety. Over the past two years, the popularity of weekly injections for weight loss has soared.

These famous faces have opened up about their differing weight loss journeys Leah Puttkammer/FilmMagic; Alexander Tamargo/Getty; Gilbert Flores/Variety via Getty People can seek to lose weight for ...

which studied 25 milligram dose of oral semaglutide compared to placebo in 307 adults with obesity with one or more comorbidities. The company is also studying weight-loss pill amycretin ...

At the least, the new 7.2mg results point to scope for hiking the semaglutide dose in CagriSema to chase down that weight-loss target. The company is also running a phase 3b trial of 7.2mg ...

New data suggests that the benefits of Novo Nordisk’s GLP-1 agonist semaglutide in preventing cardiovascular diseases may not simply be a result of weight loss. The analysis comes from long-term ...

Mounjaro is a brand of Tirzepatide, an FDA-approved drug originally created to treat Type 2 diabetes but has also been found to aid in weight loss. In the past three to four weeks, the daughter of ...

Eli Lilly LLY-5.46%decrease; red down pointing triangle revenue surged in the latest quarter on steady sales of Mounjaro and other weight-loss treatments in its portfolio. The drug maker logged ...